Why treat non-alcoholic fatty liver disease?

Abstract

The article considers the problem of non-alcoholic fatty liver disease, analyzes the main etiopathogenic aspects and risk factors such as obesity, insulin resistance and other. The treatment regimen with pathogenically relevant drugs, including the new generation hepatorpotectors, is discussed.

Keywords

• неалкогольная жировая болезнь печени
• факторы риска
• ожирение
• инсулинорезистентность
• дислипидемия
• гепатопротекторы
• non-alcoholic fatty liver disease
• risk factors
• obesity
• insulin resistance
• dyslipidemia
• hepatoprotectors